Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer

J Gynecol Oncol. 2023 Jul;34(4):e46. doi: 10.3802/jgo.2023.34.e46. Epub 2023 Mar 13.


Objective: To evaluate the effect of parametrial status on FIGO stage IIIC1 cervical cancer.

Methods: A retrospective study was conducted from June 1, 2009, to December 31, 2018.Patients with stage IIIC1 cervical cancer were included and stratified into two groups based on the status of parametrial involvement. Patients with IIIA or IIIB were selected as control. The primary outcomes are overall survival (OS) and progression-free survival (PFS).

Results: Of 586 patients included, 377 patients were stage IIIC1 (group A) and 209 patients were stage IIIA/IIIB (group B). Compared control, stage IIIC1 was not associated with worse 5-year OS or PFS. Of the stage IIIC1 patients, 58.1% without parametrial involvement (group A1) and 41.9% with parametrial involvement (group A2). Patients of group A1 showed a better prognosis than group A2 both in 5-year rates of OS (79.09% vs. 59.43%, p<0.001) and PFS (73.27% vs. 56.95%, p=0.0002). However, patients of group A1 showed a better prognosis than group B both in OS and PFS. Also, patients of group A2 showed a comparable prognosis to group B both in OS and PFS.

Conclusion: Reclassification of stage IIIC1 cervical cancer without parametrial into a new stage is more appropriate and improves discriminatory ability.

Keywords: Cancer Stage; Cervical Cancer; Lymph Node; Metastasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Humans
  • Neoplasm Staging
  • Prognosis
  • Progression-Free Survival
  • Retrospective Studies
  • Uterine Cervical Neoplasms* / pathology

Grants and funding